2025-06-16-Jefferies-NFIL（NFIL）_资本支出货币化加速_15页_644kb

Analysis Summary: Navin Fluorine International Equity Research Report

Company Overview: Navin Fluorine International Ltd (NFIL) is a leading manufacturer of fluorochemicals, with segments in refrigerants, specialty chemicals, inorganic fluorides, and contract research and manufacturing services. Jefferies rates the stock as Buy, highlighting its position in high-value sectors like pharmaceuticals and high-power packs (HPP), with a price target of INR 5,280 (50x forward FY27E EPS).

Investment Recommendation: Maintain Buy stance due to potential 35% EPS compound annual growth rate (CAGR) from FY25-27E, driven by monetization of INR 20bn in capex from FY23-25, improved asset utilization, and a strong pipeline of contracts. The stock has underperformed Nifty by 23% since Jan-23 despite recent gains. Key valuation risks include execution delays in new projects and management churn.

Financial Highlights: Expects strong revenue and EBITDA growth, with FY26E/27E EPS CAGR at 31-35%. Current asset turnover has declined but shows improvement potential. Financials indicate rising debt (net debt/EBITDA ratio ~1.7x FY25) amid expanding capex and operational efficiencies.

Valuation: 12-month price target set at INR 5,280, reflecting optimistic medium-term growth. Current P/E is 50x forward, with EV/EBITDA multiples projected to remain attractive in line with peers.

Risks: Downside includes potential commodity chemical weakness, project execution delays, and heightened scrutiny from R32/chemical industry regulations. Competitors like Bayer and Corteva pose indirect threats.

Key Growth Drivers: Long-term contracts with Corteva, Chemours, and Bayer; expansion in specialty chemicals, CDMO services (aiming for INR 100mn revenue by FY27), and R-32 refrigerants. Sustainability initiatives, such as reducing hazardous waste, could mitigate non-financial risks.